These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 2882050)
1. Anti-ulcer drugs in antisecretory doses for "cytoprotection" in arthritic patients? Londong W Klin Wochenschr; 1986; 64 Suppl 7():32-4. PubMed ID: 2882050 [TBL] [Abstract][Full Text] [Related]
2. The therapeutic efficacy of misoprostol in peptic ulcer disease. Watkinson G; Hopkins A; Akbar FA Postgrad Med J; 1988; 64 Suppl 1():60-77. PubMed ID: 3138682 [TBL] [Abstract][Full Text] [Related]
3. NSAID-induced gastrointestinal damage. A critical review of prophylaxis and therapy. McCarthy DM J Clin Gastroenterol; 1990; 12 Suppl 2():S13-20. PubMed ID: 1978842 [TBL] [Abstract][Full Text] [Related]
4. Proton-pump inhibitors reduce the risk of uncomplicated peptic ulcer in elderly either acute or chronic users of aspirin/non-steroidal anti-inflammatory drugs. Pilotto A; Franceschi M; Leandro G; Paris F; Cascavilla L; Longo MG; Niro V; Andriulli A; Scarcelli C; Di Mario F Aliment Pharmacol Ther; 2004 Nov; 20(10):1091-7. PubMed ID: 15569111 [TBL] [Abstract][Full Text] [Related]
5. Prevention and treatment of ulcers induced by nonsteroidal anti-inflammatory drugs: an update. Dajani EZ; Agrawal NM J Physiol Pharmacol; 1995 Mar; 46(1):3-16. PubMed ID: 7599335 [TBL] [Abstract][Full Text] [Related]
6. Prevention and treatment of non-steroidal anti-inflammatory drug-induced gastro-duodenal damage: rationale for the use of antisecretory compounds. Scarpignato C; Pelosini I Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S63-72. PubMed ID: 10379472 [TBL] [Abstract][Full Text] [Related]
7. The impact of nonsteroidal anti-inflammatory drug-induced gastropathy. Scheiman JM Am J Manag Care; 2001 Feb; 7(1 Suppl):S10-4. PubMed ID: 11225347 [TBL] [Abstract][Full Text] [Related]
8. Pharmacological management of patients with peptic ulcer disease: prospects for the late 1980's. Thomson AB; Mahachai V Clin Invest Med; 1987 May; 10(3):152-70. PubMed ID: 2887321 [TBL] [Abstract][Full Text] [Related]
9. A clinical approach to management of patients with non-steroidal anti-inflammatory gastropathy. Yeomans ND Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S89-92. PubMed ID: 10379475 [TBL] [Abstract][Full Text] [Related]
10. Prevention and treatment of gastrointestinal symptoms and complications due to NSAIDs. McCarthy DM Best Pract Res Clin Gastroenterol; 2001 Oct; 15(5):755-73. PubMed ID: 11566039 [TBL] [Abstract][Full Text] [Related]
11. Addition of misoprostol to ranitidine in non-responders to H2-blockers and pirenzepine. Walker S; Sarem-Aslani A; Treiber G; Klotz U; Bode JC Neth J Med; 1991 Feb; 38(1-2):18-23. PubMed ID: 1674363 [TBL] [Abstract][Full Text] [Related]
13. Cytoprotection of gastroduodenal mucous membrane with analogues of prostaglandins. Lauritsen K; Laursen LS; Rask-Madsen J Recenti Prog Med; 1989 Jun; 80(6):344-52. PubMed ID: 2672199 [TBL] [Abstract][Full Text] [Related]
14. Nonsteroidal antiinflammatory drugs and the gastrointestinal tract. Hirschowitz BI Gastroenterologist; 1994 Sep; 2(3):207-23. PubMed ID: 7987619 [TBL] [Abstract][Full Text] [Related]
15. [Therapy and prevention of peptic lesions by prostaglandins]. Müller P; Dammann HG; Simon B Z Gastroenterol; 1987 Aug; 25 Suppl 3():166-74. PubMed ID: 3116777 [TBL] [Abstract][Full Text] [Related]
17. Review article: prevention of non-steroidal anti-inflammatory drug gastrointestinal complications--review and recommendations based on risk assessment. Chan FK; Graham DY Aliment Pharmacol Ther; 2004 May; 19(10):1051-61. PubMed ID: 15142194 [TBL] [Abstract][Full Text] [Related]
18. Treatment and prevention of nonsteroidal anti-inflammatory drug induced gastrointestinal mucosal injury. Agrawal NM; Dajani EZ Int J Clin Pharmacol Res; 1989; 9(6):347-57. PubMed ID: 2576801 [TBL] [Abstract][Full Text] [Related]